Answers are grounded in this paper and cite their sources.
Our findings provide the initial national OS estimates for molecularly-defined diffuse gliomas in the United States and illustrate the importance of incorporating such data into cancer registry reporting.
No takes yet. Share an insight, caveat, or question.
Ostrom et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: